InvestSMART

Beamtree Holdings Limited (ASX:BMT)

ALERT: Price-sensitive ASX Announcement for BMT
Current share price for BMT : $0.130 -0.085 (-39.53%)+
Announcement
Release
15 Oct 2025 9:23AM
Price at Release
$0.215
Full Release
download
Summary
Beamtree Holdings Limited reported a successful Q1 FY26 with a 9% increase in recurring revenue compared to the previous year. Key achievements included securing four new Abbott licenses contributing significantly to revenue, and deploying a new autonomous clinical coding solution across several countries. The company also announced a strategic collaboration with the NHS Confederation in the UK, due to launch in Q3 FY26. Stuart MacDonald was appointed as Non-Executive Director to help scale product and international growth. Despite a slight reduction in cash reserves due to investments, Beamtree shows strong operational momentum and a promising future outlook.
Key Points
  • 9% increase in recurring revenue for Q1 FY26.
  • Four new Abbott licenses secured.
  • New autonomous clinical coding solution deployed.
  • Collaboration with NHS Confederation in the UK.
  • Stuart MacDonald appointed as Non-Executive Director.
  • Strong operational momentum and future outlook.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.